David Montani

Active 1994–2025

222
Papers
31,830
Citations
94
h-index
208
i10-index

Citations

Citations per year for David Montani1993: 1 citations1995: 5 citations1996: 1 citations1997: 8 citations1998: 4 citations1999: 4 citations2000: 3 citations2001: 3 citations2002: 3 citations2003: 7 citations2004: 6 citations2005: 1 citations2006: 1 citations2007: 4 citations2008: 12 citations2009: 48 citations2010: 58 citations2011: 82 citations2012: 145 citations2013: 219 citations2014: 196 citations2015: 188 citations2016: 228 citations2017: 193 citations2018: 264 citations2019: 847 citations2020: 1,305 citations2021: 1,584 citations2022: 1,429 citations2023: 819 citations2024: 1,547 citations2025: 659 citations2026: 17 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,296 citing papers, 22% of this breakdownChina: 896 citing papers, 8.6% of this breakdownUnited Kingdom: 841 citing papers, 8.1% of this breakdownFrance: 752 citing papers, 7.2% of this breakdownGermany: 689 citing papers, 6.6% of this breakdownItaly: 492 citing papers, 4.7% of this breakdownCanada: 445 citing papers, 4.3% of this breakdownNetherlands: 351 citing papers, 3.4% of this breakdownSpain: 287 citing papers, 2.7% of this breakdownJapan: 279 citing papers, 2.7% of this breakdownAustralia: 243 citing papers, 2.3% of this breakdownBelgium: 235 citing papers, 2.2% of this breakdown
0%22%Other 25.2%

Fields

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Engineering2.5%
  • Immunology and Microbiology1.7%
  • Neuroscience0.7%
  • Computer Science0.3%
  • Other1.8%

Topics

  • Pulmonary Hypertension Research and Treatments17.7%
  • COVID-19 Clinical Research Studies3.9%
  • Long-Term Effects of COVID-193.8%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.6%
  • Cardiovascular Function and Risk Factors3.2%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.6%
  • Other65.2%

Coauthors

All papers

Open in search
  1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

    Authors: , , , , , , , - European Respiratory Journal 2018 cited by 3,806

  2. Sotatercept for the Treatment of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 585

  3. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

    Authors: , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 145

  4. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 cited by 198

  5. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 cited by 1,387

  6. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 700

  7. Definition, classification and diagnosis of pulmonary hypertension

    Authors: , , , , , , , - European Respiratory Journal 2024 cited by 371

  8. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raymond L. Benza, Nitin Bhatt, Harm Jan Bogaard, Charles D. Burger, Murali M. Chakinala, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Cesare Danesino, Stéphanie Debette, C. Gregory Elliott, Jean Elwing, Mélanie Eyries, Terry Fortin, André Franke, Robert P. Frantz, Adaani Frost, Joe G. N. Garcia, Stefano Ghio, Hossein-Ardeschir Ghofrani, J. Simon R. Gibbs, John B. Harley, Hua He, Nicholas S. Hill, Russel Hirsch, Arjan C. Houweling, Luke Howard, D. Dunbar Ivy, David G. Kiely, James R. Klinger, Gábor Kovács, Tim Lahm, Matthias Laudes, Rajiv D. Machado, Robert V. MacKenzie Ross, Keith Marsolo, Lisa J. Martin, Shahin Moledina, David Montani, Steven D. Nathan, Michael Newnham, Andrea Olschewski, Horst Olschewski, Ronald J. Oudiz, Willem H. Ouwehand, Andrew J. Peacock, Joanna Pepke‐Żaba, Zia Ur Rehman, Ivan M. Robbins, Dan M. Roden, Erika B. Rosenzweig, Ghulam Saydain, Laura Scelsi, Robert Schilz, Werner Seeger, Christian M. Shaffer, Robert W. Simms, Marc A. Simon, Olivier Sitbon, Jay Suntharalingam, Haiyang Tang, Alexander Tchourbanov, Thenappan Thenappan, Fernando Torres, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, Quinten Waisfisz, Anna K. Walsworth and 18 more - The Lancet Respiratory Medicine 2018 cited by 213

  9. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 451

  10. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Poubeau, Grégoire Prévôt, Sébastien Renard, Martine Reynaud‐Gaubert, Marianne Riou, P. Roblot, Olivier Sanchez, Andrei Seferian, Cécile Tromeur, Jason Weatherald, Gérald Simonneau, David Montani, Marc Humbert, Olivier Sitbon - American Journal of Respiratory and Critical Care Medicine 2021 cited by 197

  11. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 cited by 226

  12. Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ofer Nativ, Zaher Bahouth, Dayou Shi, Wei Zhang, Qingling Hua, Yue-yin Pan, Tao Li, Hu Liu, Amir Karban, Eduard Koifman, Tova Rainis, Roberts Škapars, Armands Sīviņš, Guntis Ancāns, Inta Liepniece‐Karele, Ilze Ķikuste, Ieva Lašina, Ivars Tolmanis, Douglas Johnson, Stuart Z. Millstone, Jennifer A. Fulton, John W. Wells, L HABELSON WILF, Marc Humbert, Mārcis Leja, Nir Peled, Hossam Haick - ACS Nano 2016 cited by 496

  13. Post-acute COVID-19 syndrome

    Authors: , , , , , , , , , , , , , , , - European Respiratory Review 2022 cited by 268

  14. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management

    Authors: , , , , , , , - The Lancet Respiratory Medicine 2023 cited by 119

  15. Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 101

  16. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Girerd, Arjan C. Houweling, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Robert V. MacKenzie Ross, Shahin Moledina, David Montani, Michael Newnham, Andrea Olschewski, Horst Olschewski, Andrew J. Peacock, Joanna Pepke‐Żaba, Inga Prokopenko, Christopher J. Rhodes, Laura Scelsi, Werner Seeger, Florent Soubrier, Dan F. Stein, Jay Suntharalingam, Emilia M. Swietlik, Mark Toshner, David A. van Heel, Anton Vonk Noordegraaf, Quinten Waisfisz, John Wharton, Stephen J. Wort, Willem H. Ouwehand, Nicole Soranzo, Allan Lawrie, Paul D. Upton, Martin R. Wilkins, Richard C. Trembath, Nicholas W. Morrell - Nature Communications 2018 cited by 384

  17. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 71

  18. Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 cited by 650

  19. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaquelina O. Arakaki, G. Meyer, Rogério Souza, David Langleben, Hikmet Al‐Hiti, Pavel Jansa, Søren Mellemkjær, Fabrice Bauer, David Montani, Gérald Simonneau, Daniel Drömann, H-A Ghofrani, Ekkehard Grünig, Michael Halank, Matthias Held, Marius M. Hoeper, Hans Klose, Nikolaus Kneidinger, Hanno Leuchte, Christian Opitz, Stephan Rosenkranz, Heinrike Wilkens, Hubert Wirtz, Haralampos Karvounis, Georgia Pitsiou, Stylianos E. Orfanos, Michael D’Alto, Stefano Ghio, CD Vizza, Patrizio Vitulo, T. Nakayama, Hisataka Maki, Shunsuke Tatebe, Manuel Ibarra, Tomás Pulido, Arie P.J. van Dijk, Anton Vonk Noordegraaf, Tomasz Roleder, G. Castro, MJ Loureiro, Susana Robalo-Martins, Joan Albert Barberà, M Lázaro, GM Perez-Penate, Antonio Román, C-C Cheng, C-H. Hsu, H-H Hsu, Erhan Atahan, N Mogulkoc Bishop, NG Okumus, Zeynep Pınar Önen, Chang Hj, S-A Chang, Jin Sun Lee, H-K Kim, JG Coghlan, PA Corris, Colin Church, Robin Condliffe, J. Simon R. Gibbs, AJ Peacock, Stephen J. Wort, Roblee P. Allen, Samuel A. Allen, Rana Awdish, RL Benza, Shilpa A. DeSouza, Jeremy Feldman, Shilpa Johri and 12 more - The Lancet Respiratory Medicine 2021 cited by 161

  20. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , - Circulation Research 2022 cited by 76

  21. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 cited by 628

  22. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2019 cited by 281

  23. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 cited by 165

  24. Pulmonary veno-occlusive disease

    Authors: , , , , , , , , , , , , , , - European Respiratory Journal 2016 cited by 512